Financial Times reports Johnson & Johnson (JNJ.N) is seeking to acquire ophthalmology biotech Ollin Biosciences for up to $3.4 billion.

2026-11-16

Financial Times reports Johnson & Johnson (JNJ.N) is seeking to acquire ophthalmology biotech Ollin Biosciences for up to $3.4 billion.